SIPPR LNG IUS

Description: An levonorgestrel IUS developed by SIPPR.

Product Details

Duration: 5 years

Dose: 30 mg

Active Pharmaceutical Ingredient (API):

Inactive material: silicon rubber

Status Details

Began discovery in: 2006

Status Details:
  • The SIPPR product was compared to Mirena in rabbits and found to produce similar LNG plasma concentrations and similar histology in rabbit reproductive organs. Clinical testing in humans is planned.

Additional Information

Vertical Tabs

Print